Insulin biosimilar(GEROPHARM)

N/A

Report date: 2025/03/07 17:34:43

Base Information

Drug NameInsulin biosimilar(GEROPHARM)
Drug Alias NameGP-40211
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionOrnithine decarboxylase stimulantsProtein-tyrosine kinases inhibitorsPhosphokinases stimulants
TargetsProtein-tyrosine kinasesOrnithine decarboxylasePhosphokinases
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeropharm
China Registration ClassN/A

Develop Information

Active CompaniesGeropharm
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A